Bayer HealthCare AG
Bayer HealthCare AG, a prominent subsidiary of Bayer AG, is headquartered in Leverkusen, Germany. Established in 1863, the company has evolved into a global leader in the pharmaceutical and life sciences industry, with significant operations across Europe, North America, and Asia. Bayer HealthCare focuses on key business areas such as prescription pharmaceuticals, consumer health products, and animal health, offering innovative solutions that address critical health challenges. Its core products, including advanced therapies in oncology, cardiology, and women's health, are distinguished by their commitment to research and development. With a strong market position, Bayer HealthCare has achieved numerous accolades for its contributions to healthcare, consistently prioritising patient needs and scientific excellence. The company's dedication to innovation and quality continues to set it apart in a competitive landscape.
DitchCarbon Score
How does Bayer HealthCare AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer HealthCare AG's score of 90 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bayer HealthCare AG, headquartered in Germany (DE), currently does not have specific carbon emissions data available for the most recent year. The company is part of a corporate family that includes Bayer Aktiengesellschaft, from which it inherits emissions data and climate commitments. Bayer Aktiengesellschaft has set ambitious climate targets, which are cascaded down to Bayer HealthCare AG. These include commitments to reduce emissions across various scopes, although specific reduction targets for Bayer HealthCare AG are not detailed. The initiatives from Bayer Aktiengesellschaft encompass participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the Climate Pledge, indicating a strong commitment to sustainability and climate action. As a merged entity, Bayer HealthCare AG aligns its climate strategies with those of its parent company, Bayer Aktiengesellschaft, which is actively working towards significant reductions in greenhouse gas emissions. However, without specific emissions data or reduction targets available for Bayer HealthCare AG, the focus remains on the overarching commitments from its parent organization.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2006 | 2007 | 2008 | 2009 | 2010 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 5,710,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 3,670,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bayer HealthCare AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
